Study finds durable responses to immunotherapy in rare angiosarcomas

[News]

In a small study of 16 patients with the rare cancer angiosarcoma, tumors in four patients partially or completely responded to treatment with a combination of the immunotherapy drugs ipilimumab and nivolumab.

More... (https://www.news-medical.net/news/20210813/Study-finds-durable-responses-to-immunotherapy-in-rare-angiosarcomas.aspx)